Bexicaserin
(3R)-N-(2,2-difluoroethyl)-3-methyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-5-carboxamide
Molecular Identity
Bexicaserin
(3R)-N-(2,2-difluoroethyl)-3-methyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-5-carboxamide
PubChem CID: 122662787
2D Structure
Properties
C15H19F2N3O
Molecular Formula
295.33
Molecular Weight
g/mol
295.1496
Exact Mass
Da
1.7
XLogP
Drug-like (Lipinski: < 5)
44.4
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
5
H-Bond Acceptors
393
Complexity
SMILES
Canonical SMILES
SMILES: CC1CN2CCNCC3=C2C1=C(C=C3)C(=O)NCC(F)FIsomeric SMILES
SMILES: C[C@H]1CN2CCNCC3=C2C1=C(C=C3)C(=O)NCC(F)FSynonyms(20)
Bexicaserin2035818-24-5AN352LP352R8XR1D6SCBAN-352LP-352OP-352AR503352AR-503352C17111548-GC-17111548-GJ09106J-09106RefChem:1079736
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Bexicaserin
Loading drug network...